 Kimberly Nordstrom
Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Emergency Service, Hospital | 25 | 2026 | 2381 | 1.840 |
Why?
| | Emergency Services, Psychiatric | 6 | 2019 | 31 | 1.380 |
Why?
| | Mental Disorders | 11 | 2026 | 1163 | 1.320 |
Why?
| | Psychoses, Substance-Induced | 3 | 2016 | 16 | 1.020 |
Why?
| | Psychomotor Agitation | 4 | 2019 | 69 | 1.020 |
Why?
| | Conversion Disorder | 1 | 2025 | 10 | 0.890 |
Why?
| | Sinus Thrombosis, Intracranial | 1 | 2025 | 25 | 0.880 |
Why?
| | Headache | 2 | 2025 | 151 | 0.850 |
Why?
| | Muscle Weakness | 1 | 2025 | 92 | 0.840 |
Why?
| | Substance Withdrawal Syndrome | 2 | 2016 | 185 | 0.820 |
Why?
| | Diagnosis, Differential | 9 | 2025 | 1508 | 0.680 |
Why?
| | Haloperidol | 2 | 2019 | 32 | 0.610 |
Why?
| | Thyroid Crisis | 2 | 2017 | 8 | 0.610 |
Why?
| | Schizophrenia | 3 | 2019 | 453 | 0.570 |
Why?
| | Hypercalcemia | 1 | 2018 | 22 | 0.560 |
Why?
| | Cannabis | 2 | 2015 | 509 | 0.540 |
Why?
| | Emergency Medicine | 5 | 2019 | 282 | 0.530 |
Why?
| | Antipsychotic Agents | 4 | 2019 | 211 | 0.520 |
Why?
| | Benzodiazepines | 2 | 2016 | 168 | 0.500 |
Why?
| | Guideline Adherence | 1 | 2021 | 586 | 0.490 |
Why?
| | Korsakoff Syndrome | 1 | 2016 | 2 | 0.490 |
Why?
| | Neuroleptic Malignant Syndrome | 1 | 2016 | 2 | 0.480 |
Why?
| | Thiamine | 1 | 2016 | 19 | 0.480 |
Why?
| | Vitamin B Complex | 1 | 2016 | 39 | 0.480 |
Why?
| | Serotonin Syndrome | 1 | 2015 | 4 | 0.460 |
Why?
| | Goals | 1 | 2017 | 184 | 0.460 |
Why?
| | Interdisciplinary Studies | 1 | 2015 | 30 | 0.450 |
Why?
| | Hypokalemia | 1 | 2015 | 24 | 0.440 |
Why?
| | Mass Screening | 6 | 2026 | 1360 | 0.440 |
Why?
| | Psychotic Disorders | 4 | 2019 | 189 | 0.430 |
Why?
| | Medical Staff, Hospital | 1 | 2015 | 80 | 0.430 |
Why?
| | Long QT Syndrome | 1 | 2015 | 68 | 0.410 |
Why?
| | Alcoholism | 1 | 2016 | 822 | 0.290 |
Why?
| | Emergencies | 3 | 2017 | 174 | 0.280 |
Why?
| | Hospitalization | 1 | 2019 | 2460 | 0.280 |
Why?
| | Humans | 32 | 2026 | 145474 | 0.260 |
Why?
| | Mental Health | 2 | 2025 | 793 | 0.230 |
Why?
| | Consensus | 4 | 2025 | 477 | 0.230 |
Why?
| | Glasgow Coma Scale | 1 | 2025 | 218 | 0.210 |
Why?
| | Thiazoles | 2 | 2019 | 141 | 0.200 |
Why?
| | Practice Guidelines as Topic | 3 | 2021 | 1581 | 0.200 |
Why?
| | Risperidone | 2 | 2017 | 30 | 0.200 |
Why?
| | Medical History Taking | 2 | 2026 | 117 | 0.180 |
Why?
| | Piperazines | 2 | 2019 | 375 | 0.170 |
Why?
| | Disease Management | 2 | 2016 | 653 | 0.170 |
Why?
| | Physical Examination | 2 | 2026 | 243 | 0.170 |
Why?
| | Sweating | 2 | 2017 | 43 | 0.150 |
Why?
| | Adult | 11 | 2026 | 40777 | 0.140 |
Why?
| | Female | 13 | 2025 | 78844 | 0.140 |
Why?
| | Steroids | 2 | 2016 | 160 | 0.140 |
Why?
| | Midazolam | 1 | 2019 | 73 | 0.140 |
Why?
| | Advisory Committees | 2 | 2017 | 229 | 0.140 |
Why?
| | Geriatrics | 1 | 2019 | 95 | 0.130 |
Why?
| | Vital Signs | 1 | 2017 | 46 | 0.130 |
Why?
| | Preventive Health Services | 1 | 2019 | 153 | 0.130 |
Why?
| | Informed Consent | 1 | 2019 | 198 | 0.130 |
Why?
| | Surgical Clearance | 1 | 2017 | 6 | 0.130 |
Why?
| | Middle Aged | 7 | 2019 | 36215 | 0.130 |
Why?
| | Flumazenil | 1 | 2016 | 8 | 0.120 |
Why?
| | Phenobarbital | 1 | 2016 | 21 | 0.120 |
Why?
| | Pheochromocytoma | 1 | 2017 | 67 | 0.120 |
Why?
| | Muscle Rigidity | 1 | 2016 | 3 | 0.120 |
Why?
| | Delusions | 1 | 2016 | 9 | 0.120 |
Why?
| | Hypotension | 1 | 2017 | 127 | 0.120 |
Why?
| | Psychological Tests | 1 | 2017 | 130 | 0.120 |
Why?
| | Catatonia | 1 | 2016 | 14 | 0.120 |
Why?
| | Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2016 | 22 | 0.120 |
Why?
| | Cocaine-Related Disorders | 1 | 2017 | 133 | 0.120 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2018 | 531 | 0.120 |
Why?
| | Cacao | 1 | 2015 | 7 | 0.110 |
Why?
| | Hypnotics and Sedatives | 1 | 2017 | 222 | 0.110 |
Why?
| | Electrolytes | 1 | 2015 | 54 | 0.110 |
Why?
| | Tomography, X-Ray Computed | 1 | 2025 | 2769 | 0.110 |
Why?
| | Fever | 1 | 2016 | 319 | 0.110 |
Why?
| | Polypharmacy | 1 | 2015 | 94 | 0.110 |
Why?
| | Patient Selection | 1 | 2019 | 738 | 0.110 |
Why?
| | Food | 1 | 2015 | 150 | 0.100 |
Why?
| | Pregnancy | 2 | 2025 | 7202 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 1 | 2025 | 3904 | 0.090 |
Why?
| | Risk Assessment | 2 | 2019 | 3747 | 0.090 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2019 | 1747 | 0.090 |
Why?
| | Electrocardiography | 1 | 2015 | 665 | 0.090 |
Why?
| | Male | 9 | 2019 | 72842 | 0.080 |
Why?
| | Age Factors | 1 | 2017 | 3342 | 0.080 |
Why?
| | Pregnancy Complications | 1 | 2015 | 602 | 0.080 |
Why?
| | Substance-Related Disorders | 1 | 2019 | 1102 | 0.070 |
Why?
| | Acute Disease | 2 | 2025 | 1036 | 0.070 |
Why?
| | United States | 4 | 2019 | 16098 | 0.070 |
Why?
| | Referral and Consultation | 1 | 2015 | 867 | 0.070 |
Why?
| | Quetiapine Fumarate | 1 | 2007 | 26 | 0.070 |
Why?
| | Dibenzothiazepines | 1 | 2007 | 18 | 0.070 |
Why?
| | Aripiprazole | 1 | 2007 | 20 | 0.070 |
Why?
| | Aged | 3 | 2017 | 26153 | 0.070 |
Why?
| | Colorado | 1 | 2015 | 4553 | 0.060 |
Why?
| | Quinolones | 1 | 2007 | 203 | 0.050 |
Why?
| | Observational Studies as Topic | 1 | 2025 | 133 | 0.050 |
Why?
| | Delphi Technique | 1 | 2025 | 332 | 0.050 |
Why?
| | Anti-Inflammatory Agents | 2 | 2016 | 477 | 0.050 |
Why?
| | Surveys and Questionnaires | 1 | 2015 | 6066 | 0.050 |
Why?
| | Suicide | 2 | 2019 | 728 | 0.040 |
Why?
| | Research Design | 1 | 2025 | 1137 | 0.040 |
Why?
| | Loxapine | 1 | 2019 | 4 | 0.040 |
Why?
| | Lorazepam | 1 | 2019 | 26 | 0.040 |
Why?
| | Ethics, Research | 1 | 2019 | 31 | 0.040 |
Why?
| | Pandemics | 1 | 2025 | 1707 | 0.030 |
Why?
| | Plasma Exchange | 1 | 2016 | 18 | 0.030 |
Why?
| | Adrenal Gland Neoplasms | 1 | 2017 | 98 | 0.030 |
Why?
| | Health Services Research | 1 | 2019 | 391 | 0.030 |
Why?
| | Prodromal Symptoms | 1 | 2016 | 20 | 0.030 |
Why?
| | Bipolar Disorder | 1 | 2019 | 282 | 0.030 |
Why?
| | Immunoglobulins | 1 | 2016 | 162 | 0.030 |
Why?
| | Evidence-Based Medicine | 1 | 2017 | 740 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 2121 | 0.020 |
Why?
| | Autoimmune Diseases | 1 | 2016 | 468 | 0.020 |
Why?
| | Comorbidity | 1 | 2017 | 1661 | 0.020 |
Why?
| | Seizures | 1 | 2016 | 483 | 0.020 |
Why?
| | Chronic Disease | 1 | 2017 | 1808 | 0.020 |
Why?
| | Anxiety | 1 | 2017 | 1118 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 919 | 0.020 |
Why?
| | Physicians | 1 | 2017 | 955 | 0.020 |
Why?
| | Cohort Studies | 1 | 2017 | 6013 | 0.020 |
Why?
| | Child | 1 | 2025 | 22707 | 0.010 |
Why?
| | Prospective Studies | 1 | 2018 | 8057 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2017 | 8333 | 0.010 |
Why?
| | Young Adult | 1 | 2016 | 14218 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2017 | 17291 | 0.010 |
Why?
|
|
Nordstrom's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|